×
Entrez Id:
10157
Gene Symbol:
AASS
AASS
Alpha-Aminoadipic Semialdehyde Deficiency Disease
0.300
Biomarker
CTD_human
×
Entrez Id:
10157
Gene Symbol:
AASS
AASS
Chemical and Drug Induced Liver Injury
0.300
Biomarker
CTD_human
Characteristic molecular and proteomic signatures of drug-induced liver injury in a rat model.
25231249
2015
×
Entrez Id:
10157
Gene Symbol:
AASS
AASS
Chemically-Induced Liver Toxicity
0.300
Biomarker
CTD_human
Characteristic molecular and proteomic signatures of drug-induced liver injury in a rat model.
25231249
2015
×
Entrez Id:
10157
Gene Symbol:
AASS
AASS
Drug-Induced Acute Liver Injury
0.300
Biomarker
CTD_human
Characteristic molecular and proteomic signatures of drug-induced liver injury in a rat model.
25231249
2015
×
Entrez Id:
10157
Gene Symbol:
AASS
AASS
Drug-Induced Liver Disease
0.300
Biomarker
CTD_human
Characteristic molecular and proteomic signatures of drug-induced liver injury in a rat model.
25231249
2015
×
Entrez Id:
10157
Gene Symbol:
AASS
AASS
Hepatitis, Drug-Induced
0.300
Biomarker
CTD_human
Characteristic molecular and proteomic signatures of drug-induced liver injury in a rat model.
25231249
2015
×
Entrez Id:
10157
Gene Symbol:
AASS
AASS
Hepatitis, Toxic
0.300
Biomarker
CTD_human
Characteristic molecular and proteomic signatures of drug-induced liver injury in a rat model.
25231249
2015
×
Entrez Id:
10157
Gene Symbol:
AASS
AASS
Hyperlysinemia, Periodic
0.300
Biomarker
CTD_human
×
Entrez Id:
10157
Gene Symbol:
AASS
AASS
Hyperlysinemia, type I
0.400
Biomarker
GENOMICS_ENGLAND
Identification of the alpha-aminoadipic semialdehyde synthase gene, which is defective in familial hyperlysinemia.
10775527
2000
×
Entrez Id:
10157
Gene Symbol:
AASS
AASS
Hyperlysinemia, type I
0.400
Biomarker
GENOMICS_ENGLAND
Advantages and pitfalls of an extended gene panel for investigating complex neurometabolic phenotypes.
27604308
2016
×
Entrez Id:
10157
Gene Symbol:
AASS
AASS
Hyperlysinemias
0.720
GermlineCausalMutation
ORPHANET
Clinical, biochemical, molecular and therapeutic aspects of 2 new cases of 2-aminoadipic semialdehyde synthase deficiency.
23890588
2013
×
Entrez Id:
10157
Gene Symbol:
AASS
AASS
Hyperlysinemias
0.720
Biomarker
CTD_human
×
Entrez Id:
10157
Gene Symbol:
AASS
AASS
Hyperlysinemias
0.720
Biomarker
CLINGEN
On the basis of these and other results, we propose that AASS catalyzes the first two steps of the major lysine-degradation pathway in human cells and that inactivating mutations in the AASS gene are a cause of hyperlysinemia .
10775527
2000
×
Entrez Id:
10157
Gene Symbol:
AASS
AASS
Hyperlysinemias
0.720
Biomarker
CLINGEN
Hyperlysinemia is caused by mutations in AASS .
23570448
2013
×
Entrez Id:
10157
Gene Symbol:
AASS
AASS
Hyperlysinemias
0.720
Biomarker
CLINGEN
Clinical, biochemical, molecular and therapeutic aspects of 2 new cases of 2-aminoadipic semialdehyde synthase deficiency.
23890588
2013
×
Entrez Id:
10157
Gene Symbol:
AASS
AASS
Hyperlysinemias
0.720
GermlineCausalMutation
ORPHANET
Hyperlysinemia is caused by mutations in AASS .
23570448
2013
×
Entrez Id:
10157
Gene Symbol:
AASS
AASS
Hyperlysinemias
0.720
Biomarker
GENOMICS_ENGLAND
Advantages and pitfalls of an extended gene panel for investigating complex neurometabolic phenotypes.
27604308
2016
×
Entrez Id:
10157
Gene Symbol:
AASS
AASS
Hyperlysinemias
0.720
GermlineCausalMutation
ORPHANET
On the basis of these and other results, we propose that AASS catalyzes the first two steps of the major lysine-degradation pathway in human cells and that inactivating mutations in the AASS gene are a cause of hyperlysinemia .
10775527
2000
×
Entrez Id:
10157
Gene Symbol:
AASS
AASS
Hyperlysinemias
0.720
Biomarker
CLINGEN
High-throughput discovery of novel developmental phenotypes.
27626380
2016
×
Entrez Id:
10157
Gene Symbol:
AASS
AASS
Hyperlysinemias
0.720
Biomarker
GENOMICS_ENGLAND
×
Entrez Id:
10157
Gene Symbol:
AASS
AASS
Hyperlysinemias
0.720
Biomarker
CLINGEN
Conversion of lysine to saccharopine by human tissues.
4385118
1968
×
Entrez Id:
10157
Gene Symbol:
AASS
AASS
Hyperlysinemias
0.720
Biomarker
CLINGEN
Advantages and pitfalls of an extended gene panel for investigating complex neurometabolic phenotypes.
27604308
2016
×
Entrez Id:
10157
Gene Symbol:
AASS
AASS
Hyperlysinemias
0.720
Biomarker
GENOMICS_ENGLAND
On the basis of these and other results, we propose that AASS catalyzes the first two steps of the major lysine-degradation pathway in human cells and that inactivating mutations in the AASS gene are a cause of hyperlysinemia .
10775527
2000
×
Entrez Id:
10157
Gene Symbol:
AASS
AASS
Intellectual Disability
0.400
Biomarker
GENOMICS_ENGLAND
Advantages and pitfalls of an extended gene panel for investigating complex neurometabolic phenotypes.
27604308
2016
×
Entrez Id:
10157
Gene Symbol:
AASS
AASS
Lysine Alpha-Ketoglutarate Reductase Deficiency Disease
0.500
Biomarker
CTD_human